Digital Health News | pharmaphorum

News

Nerve damage-tracking pen to be used in CAR-T patients

Nerve damage is a recognised side effect of some CAR-T therapies for cancer, and one that could be spotted early using a pen device developed by UK company Manus Neurodyna

News

Lab software firm Benchling sheds staff

Benchling has seen its business grow at a healthy lick since it launched in 2012 with a mission to improve the efficiency of the biopharma R&D process, but it looks li

News

ZS mourns death of co-founder Andy Zoltners

The biopharma industry has lost another leading figure with the passing of Andy Zoltners, co-founder of ZS Associates, on the 40th anniversary of the company.

News

Moderna tags IBM for quantum leap in mRNA research

Moderna and IBM have formed a partnership to see how cutting-edge technologies like generative artificial intelligence and quantum computing could be applied to the discov

News

Arcadia’s $125m debt vehicle heads digital funding roundup

Investor sentiment for companies operating in the digital health category is likely to be somewhat shaken by the bankruptcy of pioneer

News

Gilde wraps up fresh health investment fund worth €600m

Netherlands-based investment group Gilde Healthcare has raised €600 million ($658 million) for a new transatlantic fund intended to support innovative ventures in digital

Nerve damage-tracking pen to be used in CAR-T patients

Lab software firm Benchling sheds staff

ZS mourns death of co-founder Andy Zoltners

Moderna tags IBM for quantum leap in mRNA research

Arcadia’s $125m debt vehicle heads digital funding roundup

Gilde wraps up fresh health investment fund worth €600m

Five indications added to Pharmacy First prescribing scheme

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks